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Abstract
Background Spondylodiscitis is a spinal infection
affecting primarily the intervertebral disk and the adjacent
vertebral bodies. Currently many aspects of the treatment
of pyogenic spondylodiscitis are still a matter of debate.
Purpose The aim of this study was to review the cur-
rently available literature systematically to determine the
outcome of patients with pyogenic spondylodiscitis for
conservative and surgical treatment strategies.
Methods A systematic electronic search of MEDLINE,
EMBASE, Cochrane Collaboration, and Web of Science
regarding the treatment of pyogenic spondylodiscitis was
performed. Included articles were assessed on risk of bias
according the Cochrane Handbook for Systematic Reviews
of Interventions, and the quality of evidence and strength
of recommendation was evaluated according the GRADE
approach.
Results 25 studies were included. Five studies had a high
or moderate quality of evidence. One RCT suggest that 6
weeks of antibiotic treatment of pyogenic spondylodiscitis
results in a similar outcome when compared to longer
treatment duration. However, microorganism-specific
studies suggest that at least 8 weeks of treatment is
required for S. aureus and 8 weeks of Daptomycin for
MRSA. The articles that described the outcome of surgical
treatment strategies show that a large variety of surgical
techniques can successfully treat spondylodiscitis. No
additional long-term beneficial effect of surgical treatment
could be shown in the studies comparing surgical versus
antibiotic only treatment.
Conclusion There is a strong level of recommendation
for 6 weeks of antibiotic treatment in pyogenic spondy-
lodiscitis although this has only been shown by one recent
RCT. If surgical treatment is indicated, it has been sug-
gested by two prospective studies with strong level of
recommendation that an isolated anterior approach could
result in a better clinical outcome.
Keywords Spondylodiscitis  Pyogenic  Treatment 
Systematic review  Outcome
Introduction
Spondylodiscitis, also known as vertebral osteomyelitis or
bacterial spondylitis, is the most common spinal infection,
which affects the intervertebral disk, adjacent vertebral
bodies, and occasionally also the posterior elements of the
spine [1, 2]. The incidence of spondylodiscitis ranges from
0.2 till 2.4 per 100.000 per year in the Western countries [2,
3]. Generally three types of spondylodiscitis are recog-
nized; pyogenic, granulomatous (tuberculous, brucellar,
aspergillar, and fungal), and parasitic [2, 4]. In the mid
twentieth century, the majority of the reported cases in
literature consisted of granulomatous infections with up to
59 % of the cases caused by Mycobacterium tuberculosis
[3, 5, 6]. The name granulomatous spondylodiscitis is
somewhat misleading since spinal tuberculosis typically
involves the vertebral bodies and to lesser extent the
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intervertebral disks. Nowadays, only 24 % is caused by
tuberculosis and the vast majority of the cases of spinal
infections are pyogenic [3, 5, 6]. Besides a relative increase
in pyogenic spondylodiscitis, there also appears to be an
increase in the total incidence [1, 3, 7, 8]. This increase in
incidence is thought to be caused by the aging population,
by the rise of immunosuppressed patients, of intravenous
drug use and of improved diagnostic possibilities [1, 3, 7,
8].
Although diagnostic and therapeutic possibilities have
drastically improved during the past decades, pyogenic
spondylodiscitis remains a diagnostic and therapeutic
challenge. Since it is often a complication of a distant
process causing bacteremia, the relatively nonspecific array
of symptoms of spondylodiscitis may be initially domi-
nated by the primary infection [9]. Consequently, clinical
presentation is often unclear and a considerable delay in
diagnosis frequently occurs [2, 3, 10]. Spondylodiscitis
remains a life-threatening disease with a mortality rate of
2–20 % [10, 11]. Although some therapeutic guidelines are
available, treatment of spondylodiscitis is certainly not
standardized and is mostly based on local preferences
resulting in physician-related variability [12–15]. Conser-
vative treatment, comprising of long-term antibiotics
optionally combined with bed rest and/or an orthosis,
appears to be the treatment of choice for the majority of the
patients [3]. However, there is still debate about the opti-
mal duration of intravenous and oral antibiotic treatment.
Furthermore is it unclear whether there is a relation
between treatment duration and relapse or treatment
failure.
Apart from the antibiotic treatment, some of the cases
with pyogenic spondylodiscitis may require surgical
debridement and stabilization. The indications for surgery
are compression of neurological structures, mechanical
instability, spinal deformity, and failure of adequate con-
servative treatment. However, there is an enormous varia-
tion in surgical techniques described for the treatment of
pyogenic spondylodiscitis [1–3, 10, 11]. Classically ante-
rior debridement and stabilization has been the preferred
treatment, since the anterior part of the spine is the most
commonly involved in spondylodiscitis [2]. In recent lit-
erature, however, both more elaborated combined anterior–
posterior approaches, less invasive posterior stabilization,
or transpedicular curettage and drainage have been
described [16–18]. Whereas the open surgical procedures
are thought to reduce the loss of sagittal balance and
minimize the risk of relapse, less invasive strategies are a
lower burden for the patients with potentially fewer com-
plications [16, 17].
Many fundamental aspects of the treatment of pyogenic
spondylodiscitis are still a matter of debate. Therefore, the
aim of this study was to systematically review the currently
available literature to determine the outcome; defined as
relapse rate, treatment failure and mortality; in patients
with pyogenic spondylodiscitis after the different antibiotic
and/or surgical treatments.
Methods
This systematic literature review regarding the outcomes of
treatment of pyogenic spondylodiscitis was preformed
according the PRISMA guidelines for systematic reviews
and was registered at Prospero; the international register of
systematic reviews (http://www.crd.york.ac.uk/PROS
PERO) [19, 20], registration number: CRD42015020618.
Literature search
We conducted an electronic search of databases of MED-
LINE, EMBASE, Cochrane Collaboration, and Web of
Science on the 1st of January 2015 for articles in English
language regarding treatment of spondylodiscitis that were
published since 2000 [21–24]. We used a standardized
search strategy including search keywords (spondy-
lodiscitis, vertebral osteomyelitis, osteodiscitis, discitis,
treatment, therapy, antibiotics, and surgery). In addition, to
prevent omission of relevant articles from before 2000, the
references of the included articles and recent reviews
regarding the treatment of spondylodiscitis were screened
for relevant literature [1–3, 10, 11]. Literature before 2000
was not systematically assessed since research before 2000
was predominantly focused on infections caused by
tuberculosis. Details about the used search strategy are
presented in Table 1.
Study selection
A stepwise procedure to identify relevant studies was used.
First, the title and abstract of all articles were systemati-
cally assessed using the inclusion and exclusion criteria as
described in Table 2. Second, all included articles were
assessed full text by two independent reviewers (JR and
DK). This critical appraisal was performed according to the
Cochrane Handbook for Systematic Reviews of Interven-
tions 5.1.0 [25]. In order to determine the extent of selec-
tion bias, the selection procedures and the homogeneity of
the patient populations were examined. The studies were
also assessed on the standardization of antibiotic treatment,
operative procedure and peri- and postoperative care in
order to determine the risk on performance bias. Attrition
bias was scored on the basis of percentage follow-up and
exclusion criteria. The risk on detection bias was based on
the description of how the data was acquired (for example
blinding) and how statistical analysis was performed.
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Quality assessment
The quality of evidence and strength of recommendation
was assessed according to the GRADE approach [26].
Details regarding treatment strategy (for example: antibi-
otics, thoracolumbosacral orthosis (TLSO) or surgery) and
outcome parameters (treatment duration, required addi-
tional surgery, treatment failure, relapse, and mortality)
were registered by two independent reviewers (JR and
DK). Relapse was defined as every event that required
additional conservative or surgical treatment after finishing
the initial treatment. Treatment failure was defined as
active infectious disease 1 year after start of the treatment.
Differences in risk of bias, quality of evidence, strength of
recommendation, and outcome parameters were discussed
in a consensus meeting.
Results
Study selection
A total of 1662 articles were found in the four electronic
databases (Fig. 1). After screening the titles and abstracts, 65
full-text articles were reviewed. Of these full-text manu-
scripts, 25 articles were excluded since they did not meet de
inclusion criteria. Most common reason for exclusion was
description of non-pyogenic spondylodiscitis (13 articles)
such as postoperative or tuberculosis infection. Furthermore,
16 abstracts of scientific conferences were found which were
not included in the critical appraisal. Relevant abstracts were
incorporated in the discussion section of the review. One
article published before 2000 was included after reference
tracking of included articles and de recent reviews regarding
the treatment of spondylodiscitis [6]. This resulted in 25
included studies (Table 3). Ten studies containing only a
minority of tuberculosis or postoperative infection cases
(2.9–38 %) were included in the review [16–18, 27–33]. At
total of 75 patients in the current review had tuberculosis
and 52 patients had a postoperative infection, which repre-
sented, respectively, 3.1 and 2.2 % of all included patients.
Similarly, four included study populations consisted of
0.9–13.5 % children and adolescent patients [4, 6, 27, 34].
Additionally 3 other studies contained patients between 16
and 18 years of age; however, the number of these patients
is not described [32, 35, 36]. A total number of 31 children
and adolescents have described in the included studies and
represent 1.3 % of the study population in this review [4, 6,
27, 34].
Characteristics of included studies
The majority of 25 included studies were retrospective
(n = 20) and only five were prospective. The retrospective
studies consisted of 11 retrospective comparative studies
(RCoS) and nine retrospective case series (RCS). Addi-
tionally, there were three prospective comparative studies
(PCS) and 2 randomized controlled trails (RCT) (Table 4).
The combined number of patients in all included studies
was 2407 and ranged from 20 to 351 patients per study.
Table 1 Search strategy
Database Search Limits
Medline (Spondylodiscitis [title/abstract] OR vertebral osteomyelitis [title/abstract] OR osteodiscitis [title/abstract] OR
(discitis [title/abstract] AND spondylitis [title/abstract])) AND (Treatment [title/abstract] OR therapy [title/
abstract] OR antibiotics [title/abstract] OR surgery [title/abstract])
2000–2015
English
Embase (spondylodiscitis:ab,ti OR (vertebral AND osteomyelitis:ab,ti) OR osteodiscitis:ab,ti OR (discitis:ab,ti AND






Spondylodiscitis OR (vertebral AND osteomyelitis) OR osteodiscitis OR (discitis AND spondylitis)) AND





TS = (Spondylodiscitis OR vertebral osteomyelitis OR osteodiscitis OR (discitis AND spondylitis)) AND
TS = (Treatment OR therapy OR antibiotics OR surgery)
2000–2015
English
Table 2 Inclusion and exclusion criteria
Inclusion criteria Study on the treatment of pyogenic spondylodiscitis in adult patients
Study design: meta-analysis, RCT, prospective trails, comparative studies, and large case series C100 patients
Exclusion criteria Study design: Case reports, case series\100 patients, and review articles
[50 % tuberculosis, aspergillosis, brucellosis, and postoperative infections
Studies on solitary epidural abscesses
Children (\18 years)
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The average age of the included patients was 59 years
(range 1–90 years). Sixty-one percent of the patients were
male. Mean follow-up time of the patients was 24 months
and ranged from 3 to 144 months (Table 3).
The reported treatment strategy was systemic antibiotics
alone in six studies and a combination of surgery and
systemic antibiotics in nine studies. In three studies, sys-
temic antibiotic treatment alone was compared to a com-
bination of surgery and antibiotics. Additionally, five
studies focused on the treatment of a specific type of
microorganism and two on a specific patient category
consisting of HIV patients and intravenous drug users
(IVDU).
Quality of included studies
According to the GRADE approach, the quality of evi-
dence was high in one study, moderate in four studies, and
very low in 20 studies (Table 4). The strength of recom-
mendation was strong for five studies and weak for the 20
other studies.
Outcomes of systemic antibiotic treatment
Six studies have evaluated the effect of systemic
antibiotic treatment alone (Table 5) [4, 30, 31, 35, 37,
38]. Antibiotics therapy could be targeted on the cau-
sative bacteria in 792 (89 %) of the cases. Four studies
were of a more descriptive nature and reported the
outcome after antibiotic therapy [4, 30, 35, 37]. The
reported systemic antibiotic treatment duration ranged
between 6 and 40 weeks [4, 30, 35]. Despite antibiotic
treatment, additional surgery was required in 25–55 % of
the reported cases [4, 30]. Relapse rates of 2 and 4 %
after antibiotics treatment only were reported in two
studies. Whereas one study did not report the microor-
ganisms causing the relapse, the other reported three
cases of S. aureus (one case of MRSA), and one case of
Proprionibacterium acnes. The in-hospital mortality
ranged from 1–10 % [4, 30, 35]. A recent RCT by
Bernard et al. compared 6–12 weeks of antibiotic treat-
ment and showed that the therapy can be safely short-
ened to a total of 6-week treatment without increasing
Fig. 1 Flow chart literature
search
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the risk for relapse, failure, and infection-related mor-
tality (Table 5) [38]. An earlier RCoS by Roblot et al.
supports this conclusion [31].
Outcomes of surgical treatment
Four studies compared anterior and/or posterior approa-
ches [16, 17, 29, 39]. The RCT of Linhardt et al. and the
PCoS of Si et al. both compared a combined anterior and
posterior stabilization with an isolated anterior spondy-
lodesis [29, 39]. They both reported less pain and statis-
tically significant better clinical outcomes (SF36,
Oswestry, ODI, and VAS) in the anterior only group [29,
39]. The RCoS by Vcelak et al. evaluated the differences
between a combined anterior and posterior approach and
an isolated posterior approach [17]. No statistically sig-
nificant differences in reoperation rate, relapse, treatment
failure, or mortality were found [17]. The isolated pos-
terior approach group had a statistically significant greater
loss of sagittal balance; however, this had no clinical
consequences [17].
Lee et al. retrospectively evaluated the outcome of
transpedicular curettage and drainage with posterior sta-
bilization versus an combined anterior/posterior stabi-
lization [16]. No differences in clinical outcome were
found and the transpedicular curettage, and drainage with
posterior stabilization was suggested to be a good treat-
ment for patients with severe co-morbidities [16]. Lin
et al. retrospectively assessed the difference between an
open and a percutaneous approach in a combined anterior
and posterior strategy [40]. They found no differences in
the outcomes between the open and percutaneous groups
[40]. The retrospective study by Ozturk et al. analyzed if
there was a difference between a sequential versus a
simultaneous anterior and posterior surgery [18]. No dif-
ferences were found between the two study groups [18].
Two studies retrospectively compared the effectiveness of
anterior fusion with different types of cages and cage
versus strut graft [41, 42]. Schomacher et al. compared
Polyetheretherketone (PEEK) cages with titanium (TTN)
cages [41]. No differences between the two cage types
were found [41]. The differences between iliac bone struts
and titanium mesh cages were analyzed by Yong et al.
[42]. Although there was no difference in clinical out-
come, a higher subsidence rate in the strut group was
reported [42]. The descriptive RCS by Rossbach et al.
presented the results of a cohort of patients with
spondylodiscitis and a subgroup in which the spondy-
lodiscitis was complicated by a spinal epidural abscess
[32]. Patients with a neurological deficit caused by an
epidural abscess had a statistically significant better
prognosis than patients with other causes of neurological
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Systemic antibiotics versus surgical treatment
Three studies retrospectively compared systemic antibi-
otics alone versus surgical treatment [27, 34, 43]. The
indication for surgical treatment in the first two studies
was neurologic compromise, extensive bone destruction,
epidural abscess formation, failure of nonoperative
treatment or intractable back pain. The descriptive study
by Karadimas et al. concluded that nonoperative treat-
ment was effective in 90 % of the patients; decompres-
sion alone had a high reoperation rate and no differences
in clinical outcome were found [27]. Reoperation rate for
decompression without stabilization was 42 %, whereas
combined stabilization and decompression had a reoper-
ation rate of 16 % [27]. Although this study reported the
complication and reoperation rates in detail, no statistical
analysis was performed. Similarly, the retrospective
comparative study by Valancius et al. described the
results of antibiotics alone and surgical treatment in great
detail without statistical analysis and also reported that
antibiotics therapy alone was safe and effective in
spondylodiscitis without complications [34]. In contrast
to these studies, Nastro et al. offered the patients to
choose between a TLSO for 3–4 months and bridging
percutaneous pedicle screw constructs followed by a soft
brace for 4 weeks [43]. They analyzed the differences in
the clinical outcome between these groups and report a
lower VAS, higher SG-36, and higher EQ-5D in the first
3–6 months in the surgical treatment group. However, no
statistically significant differences were found after
9 months [43] (Table 7).
Microorganism-specific treatment
Five studies focused on microorganism-specific antibiotic
treatment [28, 36, 44–46]. Jensen, Loible, and Mulleman
Table 4 Quality of included studies according the GRADE approach















Aagaard 2013 [1] RCS No No Yes Yes Very low Weak
Bernard 2014 [2] RCT No No Yes No High Strong
Hadjipavlou 2000 [3] RCS No Yes Yes Yes Very low Weak
Jensen 1998 [4] RCS No Yes Yes Yes Very low Weak
Karadimas 2008 [5] RCS No Yes No Yes Very low Weak
Lee 2014 [6] RCoS Yes Yes No Yes Very low Weak
Legrand 2011 [7] RCS No Yes Yes Yes Very low Weak
Lin 2014 [8] RCoS No No No Yes Very low Weak
Linhardt 2006 [9] RCT No Yes Yes Yes Moderate Strong
Loibl 2014 [10] RCS No Yes No Yes Very low Weak
Mulleman 2006 [11] RCS No Yes No Yes Very low Weak
Nasto 2014 [12] RCoS Yes No No Yes Very low Weak
Ozturk 2007 [13] RCoS Yes Yes No Yes Very low Weak
Park 2013 [14] PCS No Yes No Yes Moderate Strong
Parra 2012 [15] RCS No Yes No Yes Very low Weak
Rangaraja 2014 [16] RCoS No Yes No Yes Very low Weak
Roblot 2007 [17] RCoS Yes Yes Yes Yes Very low Weak
Rossbach 2014 [18] RCS No Yes Yes Yes Very low Weak
Schomacher 2014 [19] RCoS Yes Yes Yes Yes Very low Weak
Si 2013 [20] PCoS No No No Yes Moderate Strong
Sobottke 2009 [21] RCoS No Yes Yes Yes Very low Weak
Valancius 2013 [22] RCos Yes Yes No Yes Very low Weak
Vcelak 2014 [23] RCos No No No Yes Very low Weak
Wang 2012 [24] PCos No Yes Yes Yes Moderate Strong
Yong 2008 [25] RCos No Yes No Yes Very low Weak
RCS retrospective case series, RCT randomized controlled trail, RCoS retrospective comparative study, PCS prospective cohort study, PCoS
prospective comparative study
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Main conclusion of the article






42 91.9 days 0 % Relapse 10 %
Failure 0 %
0 % (ND) Transpedicular curettage and
drainage proved to be a useful
technique for treating pyogenic
spondylodiscitis in patients who
were in poor heath
Combined anterior
and posterior
surgery N = 26
65 days 6 % Relapse 0 %
Failure 0 %
0 % (ND)
Lin 2014 [8] Combined anterior
and open
posterior N = 25
84 28–83 days 0 % Relapse 8 %
Failure 0 %
0 % (ND) Anterior debridement and interbody
fusion with bone grafting followed
by minimally invasive
percutaneous posterior






posterior N = 20














Patients with an isolated ventral
spondylodesis feel significantly
better and experience significantly
less pain in the area of spinal















surgery N = 29







ND (ND) Simultaneous anterior and posterior
surgery is a good alternative
procedure. It appears to result in
less blood loss, a shorter operative















59 ND 55.6 % Relapse ND
Failure ND
ND (ND) Patients with spondylodiscitis and
neurological deficits caused by
spinal epidural abces might derive
considerable benefit from surgery
because their neurological deficits






70.3 2–4 wk IV,
8–10 wk
oral
4.8 % ND ND (ND) The application of TTN- or PEEK-
cages does not appear to influence
the radiological outcome or risk of
reinfection, neither does the extent








0 % ND ND (ND)





ND ND 0 % Relapse 8 %
Failure 0 %
ND (ND) Both procedures are safe. Patients
with anterior fixation may achieve
better postoperative results, such as





ND 0 % Relapse 0 %
Failure 0 %
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et al. described retrospective cohorts of spondylodiscitis
patients and report a higher complication rate in S. aureus
infections and a higher risk of concomitant endocarditis in
enterococcal spondylodiscitis [28, 36, 44]. As a result,
Jensen et al. advised a minimum of 8 weeks of antibiotic
treatment for S. aureus spondylodiscitis. The prospective
study by Park et al. compared methicillin-resistant S. aur-
eus (MRSA) with methicillin-susceptible S. aureus
(MSSA) [45]. A higher relapse rate was found in the
MRSA patients and again a longer antibiotic treatment was
suggested [45]. Rangaraj et al. retrospectively analyzed the
efficiency of vancomycin and Daptomycin in the treatment
of MRSA spondylodiscitis [46]. The relapse rate in the
Daptomycin groups was 3 %, whereas 30 % relapse was
found in the vancomycin group [46] (Table 8).
Treatment of HIV and IVDU patients
Two studies focused on the treatment of specific patient
groups [33, 47]. Sobottke et al. retrospectively compared
surgical with systemic antibiotics therapy alone in HIV
patients and found no statistically increased complication
or relapse rate in the surgically treated patients [33]. Wang
et al. prospectively compared the outcome of spondy-
lodiscitis in intravenous drug users (IVDUs) and non-
IVDUs [47]. A higher percentage of hardware failure and a
longer hospital stay was found in de IVDU groups; how-
ever, a higher in-hospital mortality was found in the non-
IVDU group (Table 9).
Discussion
A total of 25 studies were included in this systematic
review of English language literature comprising data from
2407 patients with pyogenic spondylodiscitis. All studies
described the outcome of conservatively or surgically
treated pyogenic spondylodiscitis. Only two RCTS and
three prospective studies were found. The quality of the
evidence was high in just one study, moderate in four
studies, and very low in the remaining 20 retrospective
studies. Based on the finding of the studies focusing on
systemic antibiotics treatment of pyogenic spondylodisci-
tis, treatment of 6 weeks results in a similar mortality,
relapse, and failure rate compared to longer treatment
duration [4, 30, 31, 35, 37, 38]. The nine articles that
described the outcome of surgical treatment strategies
show that a large variety of surgical techniques can suc-
cessfully treat spondylodiscitis, whereas the less elaborate
and less invasive approaches appear to have a better
functional outcome [16–18, 29, 32, 39–42]. So far, no
additional long-term beneficial effect of surgical treatment
could be shown in the studies comparing surgical versus
conservative treatment [27, 34, 43]. However, we should
consider that most of the surgical interventions were per-
formed in cases with complications and/or inadequate
response to a conservative approach and the groups are
difficult to compare. If surgical intervention is chosen an
isolated decompression procedure leads up to 43 % reop-























surgery N = 23
100 ND 8.7 % Relapse 8.7 %
Failure 4.3 %
4.3 (0 %) Greater loss of sagittal balance




surgery N = 8
ND 12.5 % Relapse 0 %
Failure 0 %






fixation N = 37




8.1 % Relapse ND
Failure ND
ND (ND) Single-stage anterior debridement
and cage fusion followed by
posterior pedicle screw fixation can









4.3 % Relapse ND
Failure ND
ND (ND)
IV Intravenous, WK weeks, ND not described, TLSO thoracolumboscral orthosis, SD standard deviation, MIN minimally, PEEK
polyetheretherketone, TTN titanium, SEA spinal epidural abscess
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associated with less complications and reoperations. The
five microorganism-specific studies suggest at least
8 weeks of antibiotic treatment for S. aureus spondy-
lodiscitis and Daptomycin for the treatment of MRSA
spondylodiscitis [28, 36, 44–46]. The two studies focusing
on immunosuppressed patients described that surgical
treatment in HIV patients is not associated with more
complications, while early hardware failure was more
common in surgically treated IVDUs [33, 47].
Strength and limitations
This is the first systematic literature review on the outcome
of the treatment of pyogenic spondylodiscitis comprising all
spinal regions. A literature review regarding the treatment of
cervical spondylodiscitis had been published previously
[48]. In order to obtain an evidence-based assessment of the
literature on this subject, this review was performed in
adherence to the PRISMA statement and used the GRADE
approach. We limited our search to articles published in
English, since our knowledge of other languages was not
sufficient to guarantee a valid critical appraisal. This could
have introduced a selection bias in our literature review.
Moreover, the articles published before 2000 were not sys-
tematically searched and were only screened by reference
checking of the included articles and recent relevant
reviews. This theoretically could introduce a selection bias
to our systematic literature review. However, the literature
published before 2000 predominantly concerns infections
caused by tuberculosis. Therefore, we have chosen a more
pragmatic approach as described in the ‘‘Method’’ sec-
tion. Furthermore, this review focused on clinical decision-
making and therefore case reports and small case series were
not included. The main focus of our search strategy was on
studies that compared different treatment strategies, which
might also have introduced selection bias in our search.
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effective in nine-tenths of the
patients. Decompression alone
had high a reoperation rate
compared to decompression and
internal stabilizationDecompression
without (group B
N = 56) or with
stabilization
(group C N = 37)



















100 76 days (SD
23)
0 % Relapse 0 %
Failure 0 %
0 % (ND) Surgical stabilization was
associated with faster recovery,
lower pain scores, and improved


























Conservative measures are safe
and effective for carefully
selected patients without
spondylodiscitic complications.
Failure of conservative therapy
requires surgery that can
guarantee thorough debridement,
decompression, restoration of




TLSO N = 28




IV intravenous, WK weeks, ND not described, TLSO thoracolumboscral orthosis, SD standard deviation, MIN minimally
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Next to the limitations induced by our search method-
ology, the characteristics of the included studies also
introduce their own specific bias into this review. As a
result of our aim to review the outcome of both conser-
vative and surgical treatment of pyogenic spondylodiscitis,
we have created a very heterogenic study population.
Moreover, this heterogeneity is also seen in the separate
study populations of the included articles. Fifteen of the
included studies contain a minority of patients that no
completely meet our inclusion criteria [4, 16–18, 27–36,
44]. Ten studies include a small number patients with
tuberculosis and postoperative infections representing,
respectively, 3.1 and 2.2 % of the included patient in this
review [16–18, 27–33]. Moreover seven studies included
children and adolescents representing 1.3 % of the study
population of this review [4, 27, 32, 34–36, 44]. The
patients with spondylodiscitis caused by tuberculosis could
have negatively influenced the clinical outcome since
tuberculosis has been suggested to have higher treatment
failure rates, higher risk of deformity, and more often need
surgical treatment [49, 50]. On the other hand, childhood
and postoperative spondylodiscitis are known to have a
more favorable prognosis and could have positively influ-
enced outcome results [2, 51, 52]. Final limitation of our
current review is the quality of the available evidence,
80 % of the include studies have a very low level of evi-
dence resulting in a weak level of recommendation.
Clinical implications
Conservative treatment is indicated for the majority of
pyogenic spondylodiscitis patients [3, 27, 34]. One of the
most important findings of this review is that 6 weeks of
antibiotic treatment appear to have a similar mortality,
relapse, and failure rate as 12-week treatment [31, 38]. This
was shown by the RCT of Bernard et al. and the
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longer hospital stay. Antibiotic
therapy for[8 weeks may be


















0 % (0 %) The use of daptomycin resulted in a
significantly higher rate of cure in
MRSA spondylodiscitis compared
with that of vancomycin
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retrospective study of Roblot et al. of which the RCT was
evaluated as a strong level of recommendation according
the GRADE criteria. Contrastingly, prolonged antibiotic
treatment has been suggested by other studies for
spondylodiscitis caused by S. aureus and MRSA with a
weak and strong level of recommendation, respectively [6,
30, 45]. Nevertheless, these studies focusing on S. aureus
report similar mortality, relapse, and failure rates as Ber-
nard and Roblot et al. [30, 31, 38, 44, 45]. Moreover, S.
aureus was also the most predominant microorganism in
the studies by Bernard and Roblot et al. (41 and 36 %
respectively [31, 38]). Since reduction of antibiotic treat-
ment duration in uncomplicated pyogenic spondylodiscitis,
defined as spondylodicitis without epidural abscess,
deformity or neurological deficit does not lead to an
increase in mortality, relapse, and failure rate, treatment
duration can safely be reduced to 6 weeks (2 weeks
intravenous, followed by 4 weeks oral). Due to the con-
trasting findings regarding S. aureus and MRSA, further
research is required to determine the length of antibiotic
treatment for these specific microorganisms.
Other conservative treatment options such as bed rest
and TLSO have not been investigated in detail. Therefore,
we are unable to give a level of recommendation regarding
this subject. However, a pragmatic approach with bed rest
until pain and infection parameters are decreasing and start
of mobilization with a TLSO as tolerated appear to be a
generally accepted strategy [3, 10, 11, 33–35, 43, 53].
The indications of surgical treatment have been clearly
described in literature: compression of neurological struc-
tures, spinal instability, spinal deformity, and failure of
conservative treatment [1–3, 10, 11]. This postulation was
further underscored by the included articles in this review,
although with a low level of recommendation [27, 34, 43].
Moreover, there are also some indications that surgical
treatment in uncomplicated spondylodiscitis could result in
faster recovery, faster mobilization and a better short-term
quality of life when compared to conservative treatment.
However, this is only supported by a low level of recom-
mendation without significant clinical differences after
9 months [43, 54].
Currently, many different surgical treatment strategies
are being used for the treatment of pyogenic spondy-
lodiscitis [1–3, 10, 11]. Historically anterior debridement
combined with posterior stabilization has been the golden
standard in the surgical treatment of spondylodiscitis [2].
However, since this is an elaborate procedure which can be
undesirable in critically ill patients, many different less
invasive procedures have been developed [16, 17, 29, 39,
40, 55]. Among these less invasive procedures are solely
anterior or posterior procedures, combined procedures with
percutaneous posterior stabilization, and percutaneous
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drainage [16, 17, 29, 39, 40, 55]. The RCT by Lindhardt
et al. and the prospective study by Si et al. demonstrated
that an isolated anterior approach results in a better clinical
outcome (SF36, Oswestry, ODI, and VAS) than a com-
bined anterior–posterior procedure [29, 39]. These two
studies were evaluated as a strong level of recommendation
according the GRADE criteria. Although prospective and
of adequate quality, it must be mentioned that these two
studies only comprise a total of 50 patients. Isolated pos-
terior approaches demonstrated to have similar mortality,
relapse, and failure rates as the combined procedures;
however, level of recommendation of these studies was
evaluated as weak [16, 17, 55]. Percutaneous posterior
methods have especially been advocated for patients in a
poor general condition [16, 56]. Based on the literature in
this review, there seems to be a trend to less elaborate
procedures with similar mortality, relapse, and failures
rates compared to the traditional methods while clinical
outcome appears to be better. Solely percutaneous posterior
procedures could be a good alternative in patients with
multiple morbidities [56, 57]. Surgical treatment of
spondylodiscitis could be more complex in specific patient
groups, for example, in IVDUs where early hardware
failure and surgical site infections were more common
[47]. Interestingly surgical treatment in HIV patients is not
related with higher complication rates [33]. This might be
explained by the fact that outcome of spondylitis in this
patient group is much more related to the HIV disease
severity than the chosen treatment strategy [58].
As one of the study characteristics we reported, the
percentage of positive cultures for each included study. The
percentage of positive cultures ranges from 42–100 % in
the current review. The assumption that identification of
the causative microorganism leads to more effective
treatment is well established; however, there are no studies
available to support this hypothesis [2, 9, 59]. On the
contrary, the recent study by Kim et al. showed a more
favorable outcome in empirical treated patient versus
patients with microbiologically confirmed spondylodiscitis.
Kim et al. suggest that the patients with culture negative
spondylodiscitis often have a less severe infection and
therefore a more better outcome [59]. In our review, no
difference in outcome is seen between the studies with a
low percentage of positive cultures versus studies with a
high percentage.
Future research
At this moment, there is insufficient high-quality data
available to create a complete evidence-based guideline
with strong recommendations for the treatment of pyogenic
spondylodiscitis. More prospective and preferably
randomized studies are required. Besides an increase in
data quality, a change in research focus is also desirable.
Although only 10–20 % of the patients with pyogenic
spondylodiscitis may require a surgical intervention, this is
the largest treatment group reported in the current review
(9 out of 25 articles). There seems to be a strong publi-
cation bias in favor of surgical treatment. This phenomenon
was also observed in the 16 abstracts of scientific confer-
ences found in our literature search [8, 54–56, 60–71]. Nine
of the 16 abstracts are focusing purely on surgical strate-
gies, whereas only three on the antibiotics treatment were
found. Since the vast majority of the spondylodiscitis
patients are treated conservatively more high-quality
research regarding the conservative treatment of spondy-
lodiscitis is required. Moreover many fundamental aspects
of the conservative treatment of spondylodiscitis are still
unknown and require further research. For example, a
randomized trial regarding bed rest or TLSO treatment
could be a major contribution to the treatment of pyogenic
spondylodiscitis.
Moreover, the current systematic literature review is
limited on the outcome of different treatment strategies,
whereas it has been well know that patient characteristic
also significantly influence the outcome of spondylodiscitis
[58, 72, 73]. A prognostic systematic review regarding the
effect of patient characteristic on the outcome of spondy-
lodiscitis could be a valuable addition to the available
literature.
Conclusion
The current systematic literature review summarizes the
outcome of conservatively and surgically treated pyogenic
spondylodiscitis and assesses the quality of the available
evidence. Unfortunately the majority of the included
studies had a very low level of evidence. However, there is
a strong level of recommendation for 6 weeks of systemic
antibiotics treatment in uncomplicated pyogenic spondy-
lodiscitis, although this has only been shown by one RCT.
If surgical treatment is indicated, a prospective compara-
tive study and a RCT have shown, with a strong level of
recommendation, that an isolated anterior approach could
result in a better clinical outcome compared to more
extensive combined anterior–posterior procedures.
Emerging less invasive surgical techniques should be
studied more extensively in order to gather more robust
data.
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